Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients
- 1 September 2002
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (14) , 1824-1831
- https://doi.org/10.1016/s0959-8049(02)00173-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Human recombinant erythropoietin and quality of life: a wonder drug or something to wonder about?The Lancet Oncology, 2002
- Quality of life in patients with glioblastoma participating in a randomized study of boost brachytherapyJournal of Neurosurgery, 2000
- Effect of disease burden on health-related quality of life in patients with malignant gliomasNeuro-Oncology, 2000
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000
- Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC trial 22844)European Journal Of Cancer, 1998
- The quality of life of patients with newly diagnosed M1 prostate cancer: Experience with EORTC clinical trial 30853European Journal Of Cancer, 1996
- Brain TumorsActa Oncologica, 1996
- Assessment of quality of life in clinical trialsStatistics in Medicine, 1991
- A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4Cancer, 1991
- Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapyJournal of Neurosurgery, 1989